Table 2.
Cancer Type | Stage | Waiting Time |
---|---|---|
Breast | Early | At least 2 years |
Advanced | At least 5 years | |
Colorectal | Dukes A/B | At least 2 years |
Dukes C | 2-5 years | |
Dukes D | At least 5 years | |
Bladder | Invasive | At least 2 years |
Kidney | Incidentaloma (<3 cm) | No waiting time |
Early | At least 2 years | |
Large and invasive | At least 5 years | |
Uterine | Localized | At least 2 years |
Invasive | At least 5 years | |
Cervical | Localized | At least 2 years |
Invasive | At least 5 years | |
Lung | Localized | 2-5 years |
Testicular | Localized | At least 2 years |
Invasive | 2-5 years | |
Melanoma | Localized | At least 5 years |
Invasive | Contraindicated | |
Prostate | Gleason ≤6 | No waiting time |
Gleason 7 | At least 2 years | |
Gleason 8-10 | At least 5 years | |
Thyroid (Papillary/Follicular/Medullary) | Stage 1 | No waiting time |
Stage 2 | At least 2 years | |
Stage 3 | At least 5 years | |
Stage 4 | Contraindicated | |
Anaplastic | Contraindicated | |
Hodgkin Lymphoma | Localized | At least 2 years |
Regional | 3-5 years | |
Distant | At least 5 years | |
Non-Hodgkin Lymphoma | Localized | At least 2 years |
Regional | 3-5 years | |
Distant | At least 5 years | |
Post-transplant lymphoproliferative disease | Nodal | At least 2 years |
Extra-nodal and cerebral | At least 5 years |
Adapted from the KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.